|
IL-22
|
1.0E−04
|
4.0E−03
|
11.9
|
Interleukin 22
|
|
CCR6
|
1.7E−06
|
3.7E−04
|
9.7
|
Chemokine (C–C motif) receptor 6
|
|
PTPN13
|
1.5E−09
|
8.9E−06
|
9.6
|
Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
KLRB1
|
1.5E−05
|
1.2E−03
|
7.0
|
Killer cell lectin-like receptor subfamily B, member 1
|
|
IL-17F
|
5.9E−05
|
2.9E−03
|
6.6
|
Interleukin 17F
|
|
CCL20
|
3.2E−04
|
8.2E−03
|
6.6
|
Chemokine (C–C motif) ligand 20
|
|
RORC
|
2.1E−05
|
1.5E−03
|
6.6
|
RAR-related orphan receptor C, transcript variant
|
|
IL-26
|
9.3E−06
|
9.3E−04
|
5.1
|
Interleukin 26
|
|
GPR56
|
1.4E−03
|
2.0E−02
|
4.9
|
G protein-coupled receptor 56, transcript variant 2
|
|
LGMN
|
1.6E−05
|
1.3E−03
|
4.5
|
Legumain, transcript variant 2
|
|
CTSH
|
1.5E−03
|
2.1E−02
|
4.4
|
Cathepsin H, transcript variant 1
|
|
KLF2
|
1.7E−03
|
2.2E−02
|
3.8
|
Kruppel-like factor 2 (lung)
|
|
RARRES3
|
4.9E−03
|
4.3E−02
|
3.5
|
Retinoic acid receptor responder 3
|
|
Ly9
|
8.6E−06
|
8.8E−04
|
3.5
|
Lymphocyte antigen 9, transcript variant 2
|
|
TNFSF13B
|
2.1E−05
|
1.5E−03
|
3.5
|
Tumor necrosis factor superfamily, member 13b
|
|
NLF2
|
2.8E−03
|
3.1E−02
|
3.4
|
Nuclear localized factor 2
|
|
PI16
|
6.1E−09
|
1.7E−05
|
3.3
|
Peptidase inhibitor 16
|
|
MXD4
|
1.1E−07
|
9.8E−05
|
3.3
|
MAX dimerization protein 4
|
|
HPGD
|
4.1E−06
|
5.9E−04
|
3.3
|
Hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
SNX29
|
1.9E−05
|
1.4E−03
|
3.2
|
Sorting nexin 29
|
|
TRIB2
|
2.5E−07
|
1.4E−04
|
3.2
|
Tribbles homolog 2
|
|
P2RY5
|
2.3E−07
|
1.3E−04
|
3.1
|
Purinergic receptor P2Y, G-protein coupled, 5
|
|
ZNF381
|
6.4E−06
|
7.3E−04
|
3.0
|
Zinc finger protein 831
|
|
LIME1
|
1.1E−03
|
1.8E−02
|
2.9
|
Lck interacting transmembrane adaptor 1
|
|
MAP3K4
|
4.3E−07
|
1.7E−04
|
2.9
|
Mitogen-activated protein kinase kinase kinase 4
|
|
CD96
|
1.0E−05
|
9.8E−04
|
2.8
|
CD96 molecule, transcript variant 1
|
|
GPR15
|
1.7E−06
|
3.7E−04
|
2.8
|
G protein-coupled receptor 15
|
|
PPARG
|
3.2E−06
|
5.1E−04
|
2.7
|
Peroxisome proliferator-activated receptor gamma
|
|
GLIPR1
|
6.4E−06
|
7.3E−04
|
2.6
|
GLI pathogenesis-related 1
|
|
CD52
|
3.1E−04
|
3.2E−03
|
2.3
|
CD52 molecule
|
|
ARNTL
|
3.4E−04
|
8.4E−03
|
2.2
|
Aryl hydrocarbon receptor nuclear translocator-like
|
|
FOXO3
|
5.0E−03
|
4.3E−02
|
1.7
|
Forkhead box O3 (FOXO3), transcript variant 2, mRNA
|
